品管圈活动提升静脉用药调配中心质量管理水平的探索与实践

目的：强化静脉用药调配中心质量管理,深化药学服务,营造团队合作精神,提高青年药师参与质量管理意识和解决问题能力。方法：将品管圈模式引入部门日常质量管理工作中,按品管圈活动的10个步骤实施各项活动。结果：通过开展品管圈活动,静脉用药调配中心内部差错由30.25件/周降低到16.00件/周,同时青年药师责任心、解决问题能力、工作效率、凝聚力、工作积极性、品管手法方面都得到了提高。结论：开展品管圈活动,提高了静脉用药调配中心药师解决问题的能力,减少了静脉用药调配中心内部差错,保证患儿用药安全有效,提升药学服务质量。     

品管圈在静脉用药调配中心质量管理中的实践

目的：通过开展品管圈活动,减少静脉用药调配中心（PIVAS）工作差错,提高工作质量。方法：将品管圈的管理理论、方法、手段、技巧运用于PIVAS工作质量控制之中,将工作中存在的问题逐个解决。结果：PIVAS工作差错件数由11.33件/周降至4.83件/周,其中排药环节差错由7.5件/周降至1.83件/周,调配环节差错由2.4件/周降至1.17件/周。结论：品管圈解决品质问题,目标明确、原因剖析清晰、对策措施得力,能有效发现问题、解决问题,是一种适合持续开展且行之有效的品质管理形式和载体。     

品管圈在静脉用药调配中心工作中的应用

目的：通过在静脉用药调配中心（PIVAS）开展品管圈活动,提高员工自觉参与管理的意识,减少差错的发生,保障病人用药安全。方法：充分利用品管圈的各种手法,进行差错分析,提出防范措施。结果：在PIVAS差错明显减少,由改善前的每周47.75件,下降至改善后的17.16件。结论：通过推行品管圈的活动,不断改进药事质量,提升药学服务水平。     

品管圈在静脉配置中心的应用`

目的通过在静脉药物配置中心(PIVAS)推行品管圈活动,提高员工参与管理的意识,确保临床用药安全。方法按照品管圈理论实施各项活动,分析PIVAS差错发生的主要类型,探讨并实施解决的对策,评价有形成果和无形成果,并进行持续探讨与改进。结果 PIVAS药物配置过程中的差错明显减少,由改善前的每周36.9件降低至改善后的每周17.3件。结论 PIVAS推行品管圈活动,有效降低了配置差错,提升了药学服务质量。     

品管圈在静脉药物配置中心差错分析与防范中的应用

目的通过在静脉药物配置中心（PIVAS）推行品管圈活动,提高员工参与管理的意识,减少差错发生,确保临床用药安全。方法运用各种品管手法,对PIVAS出现的各类差错进行分析,并制定相应的防范措施。结果 PIVAS药物配置过程中的差错数明显减少,由改善前的每周84.75件,降低至改善后的每周35.44件。结论通过推行品管圈活动,能够不断发现和解决PIVAS内部问题,提升药学服务质量。     

品管圈在静脉用药调配中心排药环节的应用

目的 开展品管圈活动,对静脉用药调配中心(PIVAS)排药环节进行优化,降低排药差错率,提高工作质量,保证输液安全.方法 2013年4月PIVAS成立品管圈,并确定降低排药差错率为主题,分析PIVAS排药差错的原因,按品管圈实施步骤实施各项活动,并拟定和改善措施.结果 PIVAS排药差错率由活动前的0.12%改善到活动后的0.0512%,达成率88.9%.结论 开展品管圈活动不仅有效降低了PIVAS排药差错率,还提高了科室人员参与管理的意识以及发现和解决PIVAS内部问题的能力.     

品管圈在静脉药物配置中心的实践与效果分析

目的通过在静脉药物配置中心（PIVAS）推行品管圈活动,提升药事服务质量,营造员工团队合作及学习成长的环境,提高参与管理的意识和解决问题的能力。方法以圈员自愿参与的方式,运用多种统计方法,按照品管圈实施的十大步骤进行计划、实施、确认和处置。结果PIVAS药物配置过程中的差错由改善前的平均每周84.75件降低至改善后的平均每周35.44件。结论推行品管圈活动能够不断发现和解决PIVAS的内部问题,改善工作质量,提高药学人员参与管理的意识与水平。     

品管圈活动对降低医院静脉用药集中调配中心调剂差错的成效分析

目的:分析品管圈(QCC)活动对降低医院静脉用药集中调配中心(PIVAS)调剂差错的成效,为保障患者用药安全提供参考。方法:运用QCC手法,收集数据并分析差错类型及原因,通过计划(Plan)、实施(Do)、确认(Check)和处置(Action)等一系列活动步骤,比较活动前后发生调剂差错数据差异,计算活动后改善的幅度。结果:通过QCC活动的开展,调剂差错由原先的63件/月降至27件/月,目标达成率为133.33%,提高了各圈员解决问题的能力及责任感,完善了PIVAS的操作规程。结论:通过开展QCC活动,形成了标准化操作规程,降低了调配差错,提高了工作效率,提升了药学服务质量。     

品管圈在降低静脉药物配置中心调剂过程差错中的作用

为利用品管圈降低静脉药物配置中心调剂中的差错,提高医院静脉药物配置中心配置药物的质量,保证患者用药安全。我院引入品质管理概念,引导药师积极参与质量管理的全过程,提高工作效率,增强工作责任心。结果 PIVAS药物配置过程中的调剂差错件数由改善前平均每周26件降低至平均每周10件,人员工作积极性和责任心明显增强,并且提高了工作效率。品管圈活动对降低差错,确保安全医疗效果显著,同时也增强了药师发现问题,解决问题的能力,提高了药师主动参与管理的意识。     

品管圈在静脉用药调配中心的实践与结果分析

目的:通过在静脉用药调配中心(PIVAS)推行品管圈活动,减少药物调配差错,保障患者用药安全,提高医院药事管理水平。方法:引入品质管理概念,运用多种统计方法,按照品管七大手法来解决实际工作中的问题。结果:PIVAS药物调配过程的差错由改善前的平均每月34.00例降低至改善后的平均每月17.17例。结论:将品管圈的改善方法运用于PIVAS的药物调配质量管理中,可以极大发挥整个科室团队协作能力,减少药物调配差错,提高药物调配质量,降低工作过程中的风险。     

“医”与“法”

2003年8月中,惠氏百宫制药有限公司邀请广东地区各大医院的专家和医院管理人员在广东东莞举行了一场别开生面的研讨会。会议包括两个议题:一是“特治星治疗严重呼吸道感染”的学术研讨;二是“医疗纠纷处理的新规则与新思路”的研讨。会上“热点”不断,台上、台下观点撞击精彩纷呈,这里我们摘录片段与大家共享。     

Laboratory Verification of "heavy" and "light" users of cannabis

For various experimental studies it is often desirable to classify categories of cannabis use. For instance, in a study of the kinetics of δ-9-tetrahydrocannabinol (THC) in man, we wanted to see if there were differences between “heavy” and “light” users of the drug. “Heavy” use was defined as once daily or more, while “light” use was defined as sporadic or occasional, no more frequent than once monthly.Previously, we had found that the 11-oic acid of THC was not only the major metabolite to appear in the urine but also that its appearance in urine was prompt and lasted for at least 72 hours after a single exposure [1]. We decided to use the presence of this material in urine as a marker for heavy and light use; one would expect to find it regularly in heavy users and rarely, if at all, among light users. All subjects entering the study declared their pattern of use and then were asked to provide a spontaneously voided urine, to be used for analysis of THC-11-oic acid.     

以"豆"祛"痘"

虽然早已过了青春期,但我那略显"婴儿肥"的脸上还是会不时地出现些小痘痘.为了消除这些可恶的家伙,我还真是没少折腾,又是吃药、吃保健品,又是用化妆品,可痘痘却大有"野火烧不尽,春风吹又生"之势,看来要消灭它们可不是件容易的事.     

Activity of "reversed" diamidines against Trypanosoma cruzi "in vitro"

Chagas' disease is an important parasitic illness caused by the flagellated protozoan Trypanosoma cruzi. The disease affects nearly 17 million individuals in endemic areas of Latin America and the current chemotherapy is quite unsatisfactory based on nitroheterocyclic agents (nifurtimox and benznidazol). The need for new compounds with different modes of action is clear. Due to the broad-spectrum antimicrobial activity of the aromatic dicationic compounds, this study focused on the activity of four such diamidines (DB811, DB889, DB786, DB702) and a closely related diguanidine (DB711) against bloodstream trypomastigotes as well as intracellular amastigotes of T. cruzi in vitro. Additional studies were also conducted to access the toxicity of the compounds against mammalian cells in vitro. Our data show that the four diamidines compounds presented early and high anti-parasitic activity (IC50 in low-micromolecular range) exhibiting trypanocidal dose-dependent effects against both trypomastigote and amastigote forms of T. cruzi 2h after drug treatment. Most of the diamidines compounds (except the DB702) exerted high anti-parasitic activity and low toxicity to the mammalian cells. Our results show the activity of reversed diamidines against T. cruzi and suggested that the compounds merit in vivo studies.     

"Sick" or "hooked": smokers' perceptions of their addiction

A postal questionnaire was completed by 233 smokers who had contacted a television company for help with stopping smoking. Subjects recorded how well each of 20 statements described their feelings about their own smoking. These responses were submitted to a principal components analysis which revealed two interpretable factors. The first ('Sick') reflected a tendency to see smoking as a sickness, and a greater concern over health consequences. The second ('Hooked') reflected a feeling of inability to give up smoking, and a resentment at other's attempts at dissuasion. Subjects with higher 'Sick' factor scores perceived greater potential benefit in their stopping (in terms of a reduction of risk of cancer). Higher 'Hooked' factor scores were given by females, older smokers, those who described themselves as more extremely addicted, and those who saw less benefit for themselves in stopping.